Showing results (71-80 of 104) with videos related to
Sort By:
Pageof 11
Journal of Psychiatric Research|September 8, 2015
Comparative study of the efficacy and safety between blonanserin and risperidone for the treatment of schizophrenia in Chinese patients: A double-blind, parallel-group multicenter randomized trialHuafang Li, Chen Yao, Jianguo Shi, et al.Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|February 7, 2020
Influence of More Than 5 Years of Continuous Exposure to Antipsychotics on Cerebral Functional Connectivity of Chronic SchizophreniaQi Miao, Chengcheng Pu, Zhijiang Wang, et al.Frontiers in Psychiatry|September 5, 2022
Safety and Effectiveness of Blonanserin in Chinese Patients with Schizophrenia: An Interim Analysis of a 12-Week Open-Label Prospective Multi-Center Post-marketing SurveillanceHaishan Wu, Xijin Wang, Xuejun Liu, et al.Schizophrenia Research|May 6, 2014
Disrupted resting-state functional connectivity in minimally treated chronic schizophreniaXijin Wang, Mingrui Xia, Yunyao Lai, et al.Psychiatry Research|April 9, 2013
Myosin Vb gene is associated with schizophrenia in Chinese Han populationYaguang Chen, Lin Tian, Fuquan Zhang, et al.Psychiatry and Clinical Neurosciences|December 12, 2019
Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophreniaYuan Feng, Jianguo Shi, Lili Wang, et al.Annals of General Psychiatry|October 6, 2023
Safety and effectiveness of oral medium to high dose blonanserin in patients with schizophrenia: subgroup analysis from a prospective, multicenter, post-marketing surveillance study in mainland ChinaYuan Yang, Hongmin Ge, Xijin Wang, et al.Journal of Eating Disorders|May 22, 2026
Gender differences in relationships among parenting dimensions, disordered eating, and psychological factors in adolescents: a network analysisMengting Wu, Yunshu Zhang, Ruijiao Liu, et al.BMC Psychiatry|February 22, 2023
Effectiveness and safety of blonanserin in young and middle-aged female patients with schizophrenia: data from a post-marketing surveillanceQijing Bo, Xijin Wang, Xuejun Liu, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 12, 2013
Association study of NRXN3 polymorphisms with schizophrenia and risperidone-induced bodyweight gain in Chinese Han populationXiaofeng Hu, Jishui Zhang, Chao Jin, et al.Pageof 11